Affiliate Chair Nadine Aleman spoke with PanCAN’s Paula Mukherjee about her volunteer journey and steadfast commitment to ...

Since 2003, we have awarded 240 grants to 220 scientists at 78 institutions, with a total research investment of approximately $249 million, including the competitive Research Grants Program and ...

NEW — Congress is Listening – Keep Raising Your Voice! Pancreatic cancer advocates are making their voices heard – and Congress is listening. Because of advocates like you across the country, ...

The Pancreatic Cancer Action Network (PanCAN) Executive Team is a group of dedicated professionals, some of whom have been personally touched by the disease, who bring significant experience and ...

PanCAN Chief Scientific & Medical Officer Dr. Anna Berkenblit discusses what she learned at the inaugural AACR Drug Discovery and Development conference.

The U.S. Food and Drug Administration has granted approval for a new drug targeting the mutations that drive more than 90% of pancreatic cancer cases — a sweeping advance for a disease that has few ...

The types of cancer people are getting and dying from most may be changing in the next 20 years, according to a new study. Published today in JAMA Network Open, PanCAN and our research partners at ...

This Pancreatic Cancer Awareness Month, PanCAN is inviting you to shine a light on pancreatic cancer. Let’s uplift survivors and those living with the disease, honor the lives we’ve lost and help ...

Editor’s note: It’s been 12 years since the passing of Steve Jobs. This blog, published two years ago, discusses the rare form of pancreatic cancer Jobs had, pancreatic neuroendocrine tumor. It’s been ...

American Cancer Society’s Cancer Facts & Figures 2023, released today, reports that the five-year survival rate for pancreatic cancer is now 12%, an increase of one percentage point from last year.

Despite advances in pancreatic cancer the disease is on track to become the second-leading cause of cancer-related deaths before 2030 LOS ANGELES, Calif. – (January 17, 2024) – The five-year survival ...

Editor’s note: The “Research Spotlight” series is written by Dr. Anna Berkenblit, PanCAN’s Chief Scientific and Medical Officer. Each month, Dr. Berkenblit shares her insights into the latest news and ...